Tags :cn2

Corporate

Clifford Chance advises UCB on IMIDomics deal

Clifford Chance has advised UCB, a biopharmaceutical company focused on immunology and neurology, on its acquisition of the IMIDomics Patient Insight Business, a curated patient data platform developed through a global clinical network and supported

Background

ACC Europe kicks off its annual conference in Copenhagen

From 3–5 June, Copenhagen becomes the meeting point for the in-house legal community as the ACC Europe Conference takes over the Tivoli Hotel & Congress Center for its 2026 edition — in media partnership with Legalcommunity, LegalcommunityGERMANY, Inhousecommunity,